Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eli Lilly
Eli Lilly
Lilly’s Gastric Cancer Drug Wins Approval From U.S. FDA
Bloomberg
Mon, 04/21/14 - 04:58 pm
Eli Lilly
gastric cancer
FDA
ramucirumab
No Legwork Mondays – Takeda, Eli Lilly, And Actos
Yahoo/Benzinga
Mon, 04/21/14 - 11:39 am
Takeda
Eli Lilly
Actos
diabetes
The Biggest Biotech Wins of the Week
Motley Fool
Thu, 04/17/14 - 07:46 am
biotech
Puma Biotechnology
aripiprazole lauroxil
Alkermes
neratinib
Roche
Herceptin
bemaciclib
breast cancer
Eli Lilly
Eli Lilly/ Boehringer Drug Under FDA Review
Yahoo/Zacks.com
Tue, 04/15/14 - 04:49 pm
FDA
Eli Lilly
Boehringer Ingelheim
Trajenta
empagliflozin
diabetes
type 2 diabetes
Will Cymbalta Break Eli Lilly?
Seeking Alpha
Tue, 04/15/14 - 10:11 am
Eli Lilly
Cymbalta
dulaglutide
patents
Evista
China
New attention disorder could equal a big new ADHD drug market
Fierce Pharma
Mon, 04/14/14 - 06:36 pm
Strattera
Sluggish Cognitive Tempo
Shire
Eli Lilly
attention deficit disorder
ADD
Eli Lilly vs. Canada: The Patent War Moves to Washington
WSJ Online
Mon, 04/14/14 - 06:15 pm
Canada
patents
Eli Lilly
Pfizer Vs. Eli Lilly, Novartis In Breast Cancer Race
Seeking Alpha
Mon, 04/14/14 - 08:20 am
Novartis
Pfizer
Eli Lilly
breast cancer
palbociclib
Faslodex
AstraZeneca
LY2835219
LEE011
Can This Drug Be a Game Changer for Eli Lilly?
Motley Fool
Sat, 04/12/14 - 10:25 am
Eli Lilly
bemaciclib
breast cancer
3 Breast Cancer Drugs With Big Potential
Motley Fool
Thu, 04/10/14 - 10:37 am
breast cancer
Pfizer
Novartis
Eli Lilly
LEE011
LY2835219
palbociclib
CDK 4/6 inhibitors
[video] Eli Lilly CEO: We keep investing in R&D
CNBC
Thu, 04/10/14 - 07:46 am
R&D
Eli Lilly
Pharma CEOs
John Lechleiter
Eli Lilly and T1D to partner in diabetes research collaboration
The Fly on the Wall
Wed, 04/9/14 - 08:48 am
T1D
R&D
diabetes
Eli Lilly
Investors realize that Lilly won’t lose money in product liability case
Marketwatch
Tue, 04/8/14 - 05:15 pm
investors
Eli Lilly
Takeda
diabetes
Actos
US jury hits Takeda, Eli Lilly with $9 bln penalty
Yahoo/AP
Tue, 04/8/14 - 08:56 am
Takeda
Actos
Eli Lilly
diabetes
Pfizer Breast Cancer Drug Helps Revive Discarded Strategy
Bloomberg
Mon, 04/7/14 - 08:46 am
Pfizer
Eli Lilly
palbociclib
Novartis
bemaciclib
breast cancer
CDK 4/6 inhibitors
Lilly to present data from bemaciclib as potential treatment for breast cancer
Yahoo/Reuters
Mon, 04/7/14 - 08:40 am
bemaciclib
Eli Lilly
metastatic breast cancer
CDK 4/6 inhibitors
Is an Ariad Pharmaceuticals, Inc. Acquisition Realistic?
Motley Fool
Thu, 04/3/14 - 09:41 am
M&A
Ariad Pharmaceuticals
Eli Lilly
Iclusig
Jazz Pharmaceuticals
GSK
U.S. judge upholds validity of Eli Lilly's Alimta patent
Yahoo/Reuters
Mon, 03/31/14 - 10:34 pm
Eli Lilly
Alimta
patents
Makings of a Wide Moat in Diabetes Care
Morningstar
Fri, 03/28/14 - 11:16 am
diabetes
Takeda
Sanofi
GSK
Victoza
Merck
insulin
Novo Nordisk
Afrezza
U300
Tresiba
Eli Lilly
Zacks Industry Outlook Highlights: Eli Lilly, AstraZeneca, Shire, Salix and Cubist Pharmaceuticals
Yahoo/Zacks.com
Thu, 03/27/14 - 09:47 am
Eli Lilly
Shire
Salix
AstraZeneca
Cubist Pharmaceuticals
M&A
Pages
« first
‹ previous
…
88
89
90
91
92
93
94
95
96
…
next ›
last »